• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Endothelial cell-specific chemotaxis regulator (ECSCR), Truncated

ACP18775

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18775 Target NameECSCR
Target SynonymsECSCR; ECSCR_HUMAN; Endothelial cell-specific chemotaxis regulator; Endothelial cell-specific molecule 2FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ19T08
Background Information
  • Uniprot Id

    Q19T08

  • Target Species

    Human

  • Target Name

    ECSCR

  • Target Full Name

    Endothelial cell-specific chemotaxis regulator

  • Target Function

    Regulates endothelial chemotaxis and tube formation. Has a role in angiogenesis and apoptosis via modulation of the actin cytoskeleton and facilitation of proteasomal degradation of the apoptosis inhibitors BIRC3/IAP1 and BIRC2/IAP2.

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein. Cytoplasm.

  • Target Protein Families

    ECSCR family

  • Target Tissue Specificity

    Highest expression in endothelial cells. Also detected in vascular smooth muscle, macrophages, lymphocytes, and mast cells.

  • Target Synonyms

    ECSCR; ECSCR_HUMAN; Endothelial cell-specific chemotaxis regulator; Endothelial cell-specific molecule 2

Inquire Recombinant Human Endothelial cell-specific chemotaxis regulator (ECSCR), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification